Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$8.9K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 3 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 10 most recent Form 4 transactions.
| Mar 19 | ANTX | AN2 Therapeutics, Inc. | DTOISS◆ | 66,000 | — | — | — | Open the original filing on SEC.gov |
| Mar 19 | ANTX | AN2 Therapeutics, Inc. | AGRANT◆ | 66,000 | — | — | — | Open the original filing on SEC.gov |
| Mar 19 | ANTX | AN2 Therapeutics, Inc. | DTOISS◆ | 73,665 | — | — | — | Open the original filing on SEC.gov |
| Mar 19 | ANTX | AN2 Therapeutics, Inc. | AGRANT◆ | 73,665 | — | — | — | Open the original filing on SEC.gov |
| Feb 20 | ANTX | AN2 Therapeutics, Inc. | AGRANT◆ | 77,000 | — | — | — | Open the original filing on SEC.gov |
| Feb 20 | ANTX | AN2 Therapeutics, Inc. | AGRANT | 38,000 | — | — | +47.3% | Open the original filing on SEC.gov |
| Jan 6 | ANTX | AN2 Therapeutics, Inc. | SSELL | 5,512 | $1.01 | $5.6K | -6.8% | Open the original filing on SEC.gov |
| Jan 5 | ANTX | AN2 Therapeutics, Inc. | SSELL | 3,295 | $1.00 | $3.3K | -3.9% | Open the original filing on SEC.gov |